BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 17344302)

  • 21. Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.
    Hel Z; Nacsa J; Kelsall B; Tsai WP; Letvin N; Parks RW; Tryniszewska E; Picker L; Lewis MG; Edghill-Smith Y; Moniuszko M; Pal R; Stevceva L; Altman JD; Allen TM; Watkins D; Torres JV; Berzofsky JA; Belyakov IM; Strober W; Franchini G
    J Virol; 2001 Dec; 75(23):11483-95. PubMed ID: 11689630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.
    Dalod M; Dupuis M; Deschemin JC; Goujard C; Deveau C; Meyer L; Ngo N; Rouzioux C; Guillet JG; Delfraissy JF; Sinet M; Venet A
    J Clin Invest; 1999 Nov; 104(10):1431-9. PubMed ID: 10562305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection.
    Allen TM; Yu XG; Kalife ET; Reyor LL; Lichterfeld M; John M; Cheng M; Allgaier RL; Mui S; Frahm N; Alter G; Brown NV; Johnston MN; Rosenberg ES; Mallal SA; Brander C; Walker BD; Altfeld M
    J Virol; 2005 Oct; 79(20):12952-60. PubMed ID: 16188997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.
    Loffredo JT; Burwitz BJ; Rakasz EG; Spencer SP; Stephany JJ; Vela JP; Martin SR; Reed J; Piaskowski SM; Furlott J; Weisgrau KL; Rodrigues DS; Soma T; NapoƩ G; Friedrich TC; Wilson NA; Kallas EG; Watkins DI
    J Virol; 2007 Mar; 81(6):2624-34. PubMed ID: 17192314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Human immunodeficiency virus-1 gag specific CD8+ T cell responses in long-term nonprogressors and acquired immunodeficiency syndrome patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):911-4. PubMed ID: 15730736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.
    Pohling J; Zipperlen K; Hollett NA; Gallant ME; Grant MD
    BMC Infect Dis; 2010 May; 10():129. PubMed ID: 20500844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
    Rinaldo CR; Beltz LA; Huang XL; Gupta P; Fan Z; Torpey DJ
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):481-9. PubMed ID: 7632463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional simian immunodeficiency virus Gag-specific CD8+ intraepithelial lymphocytes in the mucosae of SIVmac251- or simian-human immunodeficiency virus KU2-infected macaques.
    Stevceva L; Moniuszko M; Alvarez X; Lackner AA; Franchini G
    Virology; 2004 Feb; 319(2):190-200. PubMed ID: 14980480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
    Kinter AL; Horak R; Sion M; Riggin L; McNally J; Lin Y; Jackson R; O'shea A; Roby G; Kovacs C; Connors M; Migueles SA; Fauci AS
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):438-50. PubMed ID: 17411377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
    Tang YB; Tang XP; Jin X
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):217-9. PubMed ID: 17971925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant ex vivo cross-stimulation of CD8+ T-cells with whole soluble gag protein in HIV-infected subjects.
    Tavernier A; Jennes W; Fransen K; De Roo A; Kestens L
    J Acquir Immune Defic Syndr; 2006 Apr; 41(5):548-56. PubMed ID: 16652028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.
    Casazza JP; Betts MR; Picker LJ; Koup RA
    J Virol; 2001 Jul; 75(14):6508-16. PubMed ID: 11413318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment.
    Sandberg JK; Fast NM; Jordan KA; Furlan SN; Barbour JD; Fennelly G; Dobroszycki J; Spiegel HM; Wiznia A; Rosenberg MG; Nixon DF
    J Immunol; 2003 Apr; 170(8):4403-10. PubMed ID: 12682278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.
    Rinaldo CR; Huang XL; Fan Z; Margolick JB; Borowski L; Hoji A; Kalinyak C; McMahon DK; Riddler SA; Hildebrand WH; Day RB; Mellors JW
    J Virol; 2000 May; 74(9):4127-38. PubMed ID: 10756025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays.
    Keating SM; Bollinger RC; Quinn TC; Jackson JB; Carruth LM
    AIDS Res Hum Retroviruses; 2002 Sep; 18(14):1067-79. PubMed ID: 12396458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.
    Boaz MJ; Waters A; Murad S; Easterbrook PJ; Vyakarnam A
    J Immunol; 2002 Dec; 169(11):6376-85. PubMed ID: 12444145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between HIV Type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China.
    Wang S; Zhuang Y; Zhai S; Zhao S; Kang W; Li X; Yu XG; Walker BD; Altfeld MA; Sun Y
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):780-7. PubMed ID: 16910834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes.
    Klavinskis LS; Bergmeier LA; Gao L; Mitchell E; Ward RG; Layton G; Brookes R; Meyers NJ; Lehner T
    J Immunol; 1996 Sep; 157(6):2521-7. PubMed ID: 8805653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.